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A B S T R A C T
Tamoxifen (TAM) is a first generation-SERM administered for hormone receptor-positive (HER+) breast cancer
in both pre- and post-menopausal patients and may undergo metabolic activation in organisms that share similar
receptors and thus face comparable mechanisms of response. The present study aimed to assess whether en-
vironmental trace concentrations of TAM are bioavailable to the filter feeder M. galloprovincialis (100 ng L−1)
and to the deposit feeder N. diversicolor (0.5, 10, 25 and 100 ng L−1) after 14 days of exposure. Behavioural
impairment (burrowing kinetic), neurotoxicity (AChE activity), endocrine disruption by alkali-labile phosphate
(ALP) content, oxidative stress (SOD, CAT, GPXs activities), biotransformation (GST activity), oxidative damage
(LPO) and genotoxicity (DNA damage) were assessed. Moreover, this study also pertained to compare TAM
cytotoxicity effects to mussels and targeted human (i.e. immortalized retinal pigment epithelium – RPE; and
human transformed endothelial cells – HeLa) cell lines, in a range of concentrations from 0.5 ng L−1 to
50 μg L−1. In polychaetes N. diversicolor, TAM exerted remarkable oxidative stress and damage at the lowest
concentration (0.5 ng L−1), whereas significant genotoxicity was reported at the highest exposure level
(100 ng L−1). In mussels M. galloprovincialis, 100 ng L−1 TAM caused endocrine disruption in males, neuro-
toxicity, and an induction in GST activity and LPO byproducts in gills, corroborating in genotoxicity over the
exposure days. Although cytotoxicity assays conducted with mussel haemocytes following in vivo exposure was
not effective, in vitro exposure showed to be a feasible alternative, with comparable sensitivity to human cell line
(HeLa).
1. Introduction
In recent years, the occurrence of pharmaceuticals in the aquatic
environment is recognized as one of the worldwide emerging issues
regarding environmental quality and human health (Heberer, 2002).
Increasing consumption of medicines leads to the continuous load of
pharmaceuticals´ parent compounds and metabolites into wastewater
effluents and treatment plants (WWTPs), where low removal effi-
ciencies have been reported (Daughton, 2016; Furuhagen et al., 2014;
Hernando et al., 2006; Pereira et al., 2017). Therefore, it is well es-
tablished that several hundreds of pharmaceutical compounds are
ubiquitous in WWTPs effluents, ground and surface waters, ultimately
reaching estuarine and marine ecosystems (Frédéric and Yves, 2014;
Verlicchi and Zambello, 2014).
Among the variety of pharmaceuticals classes released into the
aquatic environment, anticancer drugs are one of the critical groups
that raise concern regarding the ecotoxicological potential risk of long-
term exposure to non-target organisms (Besse et al., 2012; Booker et al.,
2014; Rowney et al., 2009). Overall, the mode of action (MoA) of these
molecules rely on the interaction with DNA, cellular growth factors,
proteins and signalling pathways that lead to apoptosis, thus promoting
the tumor cell death (Gačić et al., 2014). Nevertheless, detrimental
effects of anticancer drugs are not restricted to the highly proliferative
cells or onto cancer drivers, thus presenting cytotoxic, mutagenic,
carcinogenic and teratogenic potential to all normal growing cells
(Mater et al., 2014; Parrella et al., 2014).
Endocrine therapy is an alternative anticancer treatment that uses
selective mechanisms of interaction with cancer targets, applied in-
dividually or in combination with cytotoxic molecules (Hoskins et al.,
2009). It consists of the administration of a structurally diverse group of
compounds that binds to the estrogen receptors α (ERα) and β (ERβ),
and may produce estrogen agonist or antagonist effects, depending of
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the targeted tissue (Goldstein et al., 2000; Paterni et al., 2014). These
molecules are referred as selective estrogen receptor modulators
(SERM) (An, 2016; Goldstein et al., 2000; Rodenas et al., 2015). The
antagonist effect following the formation of estrogen receptor-SERM
complexes is crucial for the management of hormone-dependent breast
cancer and tumor cell survival (Goldstein et al., 2000; Zheng et al.,
2007; Criscitiello et al., 2011).
Tamoxifen (TAM) is a first generation-SERM administered for hor-
mone receptor-positive (HER+) breast cancer in both pre- and post-
menopausal patients (Goetz et al., 2007). Its antitumor ability derives
from the antagonism towards the proliferative action of estrogen
through competitive binding to ERs (Goldstein et al., 2000). As a pro-
drug, TAM requires a complex metabolic activation to elicit its designed
pharmacological activity (Kisanga et al., 2005). The 4-hydro-
xytamoxifen and 4-hydroxy-N-desmethyltamoxifen (endoxifen) are the
main products of hepatic oxidation, elicited by CYP2D6 and CY3A4,
with high anti-estrogen potential in humans (Murdter et al., 2012;
Johnson et al., 2008) (Fig. 1). Since pharmaceuticals active compounds
are designed to have a specific MoA, targeting a specific metabolic and
molecular pathway in humans, their biological activity may occur in
organisms that share similar receptors and face comparable mechan-
isms of responses (Fent et al., 2006). Conservation of biomolecules
during evolution may trigger similar responses of chemicals in different
non-targeted biological systems (Franzellitti et al., 2013; Zhang et al.,
2017). Although organisms may lack homologues of estrogen receptors,
they may contain genes for estrogen-related receptors (ERRs) that, ac-
cording to (Borgatta et al., 2015) are structurally close to human ERα
and ERβ.
Assumptions based on physico-chemical properties indicate that
TAM has a high hydrophobic potential (Kow=6.3), thus prone to ad-
sorb to organic particles (Orias et al., 2015) and settle onto bottom
sediments. However, once in coastal areas, TAM as other pharmaceu-
ticals molecules, can be subject to physico-chemical and biological
conditions different from those found in freshwater environments (e.g.
salinity, pH, temperature, turbidity, organic compounds, microbial
population) and thus TAM may present different chemical behaviour
and unexpected partition over water, suspended particles and sedi-
ments, therefore a distinct persistence (Lara-Martín et al., 2014; Schmitt
et al., 2008; Weigel et al., 2002).
Ecotoxicity assays conducted with TAM, in freshwater and marine
species, showed inhibition in the larval development of the sea urchin
Spherechinus granularis (Pagano et al., 2001), a decrease in egg pro-
duction of the fish Tautogolabrus adspersus (Mills et al., 2015), and an
alteration of vitellogenin gene expression in the fish Sparus aurata L.
(García-Hernández et al., 2016) (see details in Table 1). These effects
were detected at a concentration range from ng L−1 to μg L−1, en-
compassing TAM concentrations detected in aquatic compartments
(Table 1). Despite the increasing efforts devoted to comprehend the
risks of TAM occurrence in aquatic compartments, there is still a lack of
environmental concentrations screening in coastal and marine ecosys-
tems, as well as information around its bioavailability and potential
routes of exposures that may derive toxicological effects to non-target
species (Lara-Martín et al., 2014; Roberts and Thomas, 2006; Thomas
and Hilton, 2004).
Bivalves have been extensively used in in vivo studies to assess
biological effects in relation to pharmaceuticals exposures (Cortez et al.,
2012; Gonzalez-Rey and Bebianno, 2012, 2013, 2014; Oliveira et al.,
2017a, 2017b). Regardless the MoA of pharmaceuticals, the marine
mussel Mytilus galloprovincialis has been used to assess ecotoxicological
effects including impacts at cellular level, oxidative stress, embry-
otoxicity, immunotoxicity, genotoxicity and metabolomics/tran-
scriptomic outcomes (Gonzalez-Rey and Bebianno, 2012, 2013, 2014;
Oliveira et al., 2017a, 2017b; Schmidt et al., 2011; Teixeira et al.,
2017). The cytotoxic effects of cisplatin in M. galloprovincialis after in
vivo exposure arise insights over the subtle impairments that anticancer
drugs may induce at very low concentrations, over a long-term ex-
posure time (Trombini et al., 2016). On the other hand, in vitro toxicity
assays conducted with bivalves primary cell cultures, showed to be a
Fig. 1. Metabolic pathways of tamoxifen in humans, following activation by cytochrome P450.
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simple and sensitive approach compared to whole animal models
(Binelli et al., 2009; Katsumiti et al., 2018; Katsumiti et al., 2014) and
provide basic information on the MoA of tested agents towards mole-
cular and cellular mechanisms (Zhang et al., 2017) and underpin how
different cellular models respond to complex environmental stressors
(Balbi et al., 2017). To date, there is a lack of information related to the
effects of marine organisms' cells in in vitro exposures to anticancer
drugs. Haemocytes play a key role in the immune defence system, by
means of phagocytosis of foreign particles or microorganisms, and in-
tracellular production of ROS following exposure to xenobiotics
(Cajaraville and Gómez-Mendikute, 2003; Lacaze et al., 2015). They
may be applied as a sensitive marker to assess human-derived impacts
on the aquatic health status (Toufexi et al., 2013).
In light of the trend of increasing concentrations of anticancer drugs
in the aquatic environment, even though below human therapeutic
doses, it is important to understand whether pharmaceuticals are likely
to pose a risk to the biota via similar metabolic pathways detected in
humans (Furuhagen et al., 2014; Mater et al., 2014). Estrogen receptor
expression varies across species and can be differentially expressed
according to tissues (McGinnis and Crivello, 2011). Human cell lines
such as the retinal pigment epithelium (RPE) cell line have shown to
express ER subtypes (Koulisis et al., 2016; Wang et al., 2015), in con-
trast to cervical carcinoma HeLa cells, in which ER does not mediate
estrogen responsive reporter expression (Klinge, 2015; Maminta et al.,
1991; Shanle and Xu, 2010).
Polychaetes are sediment dwelling organisms from estuarine and
marine benthic zones which possess high ecological relevance, besides
being an important component of an ecotoxicological toolbox to assess
the impact of contaminants in sediments due to their life habits that
provide a constant contact with chemicals adsorbed onto particles and
interstitial water (Freitas et al., 2015). Putative detrimental effects of
anticancer drugs in sediments have been depicted through biochemical
impairments in the polychaete N. diversicolor, exposed to the cytotoxic
drug cisplatin (0.1 to 100 ng Pt L−1) (Fonseca et al., 2017) and cyclo-
phosphamide (10 to 1000 ng L−1) (Fonseca et al., 2018), and the am-
phipod Corophium volutator exposed to the drug methotrexate (1 to
1000 ng L−1) (Moreira et al., 2016). Due the paucity of research to
effects of TAM to marine organisms, particularly considering their
routes of uptake, one of the aims of the present study was to investigate
whether environmental trace concentrations of TAM are bioavailable to
the filter feeder M. galloprovincialis and the deposit feeder N. diversi-
color. The in vivo approach involves the assessment of behavioural im-
pairment (burrowing kinetic impairment), neurotoxicity (AChE ac-
tivity), endocrine disruption by alkali-labile phosphate (ALP) content,
oxidative stress (SOD, CAT, GPXs activities), biotransformation (GST
activities), oxidative damage (LPO) and genotoxicity (DNA damage).
Moreover, this study also pertained to compare TAM cytotoxicity ef-
fects to mussels and targeted human (i.e. immortalized retinal pigment
epithelium – RPE; and human transformed endothelial cells – HeLa) cell
lines, in a range of concentrations from 0.5 ng L−1 to 50 μg L−1, that
encompass environmental relevant levels and those considered a worst-
case scenario.
2. Materials and methods
2.1. Chemicals
Tamoxifen analytical standard (CAS 10540-29-01) was purchased
from Sigma-Aldrich (Portugal). For safety handling of the drug, the
experimental work was performed using class II biological safety ca-
binet, with appropriate clothing (open-back, impervious chemotherapy
protection gown, double powder-free latex gloves and safety goggles).
Since TAM is not readily soluble in water, the stock solution was pre-
pared in the carrier solvent dimethyl sulfoxide (DMSO). Experimental
solutions were prepared from sequential dilutions in ultrapure Milli-Q
water, with a final concentration of 0.001% (v/v) DMSO in order to
avoid a solvent toxic effect.
2.2. In vivo bioassay with polychaetes Nereis diversicolor
Polychaetes N. diversicolor and sediment samples, for sediment
characterization purposes, were collected in an intertidal mudflat in
Mira River Estuary (SW, Portugal), during low tide, and transported
alive to the laboratory. Sediment grain size distribution and organic
matter content were determined according to methods described by
Royse (1970) and Gross (1971) (see Fonseca et al., 2018).
Animals were maintained in glass aquaria filled with aerated nat-
ural seawater (salinity 35) and sediments from the site of origin, during
5 days before testing. A total of 75 polychaetes was randomly selected
and added to each treatment, in a triplicate design (25 animals per
aquaria), in 10 L glass aquaria containing sediments and seawater (1:4
ratio, respectively). Specimens were unexposed: controls (CT0 (day 0)
and CT14 (day 14) and exposed to DMSO (0.001%), and to TAM (0.5,
10, 25 and 100 ng L−1) for 14 days. Experimental set-up was kept under
constant aeration and light period (12:12 h), and physico-chemical
parameters registered (pH 7.92 ± 0.2; temperature 19 ± 1 °C; salinity
35 ± 1). During the experiment, water was carefully renewed every
48 h avoiding sediment resuspension, with addition of DMSO (0.001%)
and TAM concentrations into water column aftermath. Animals were
not fed during the bioassay.
For burrowing and comet assays, specimens were immediately
handled and managed for respective analysis, while those regarding
Table 1
TAM Concentrations in water (ng L−1), suspended solids and sediments (ng g−1) from ground, riverine and marine waters.
Study area Groundwater River Marine Reference
Surface water Suspended solids Sediment Seawater Suspended solids Sediment
France – <5.8–25 – – – – – Coetsier et al. (2009)
Japan – – 658 0.042 – – – Azuma et al. (2017)
Germany 6–16.5 – – – – – – Reh et al. (2013)
England – 27–212 – – – – – Roberts and Thomas (2006)
England – <10 – – – – – Ashton et al. (2004)
England – 13–71 – – – – – Thomas and Hilton (2004)
England – <10–23 – – – – – Hilton et al. (2003)
Spain – 12.4–26.8 – – – – – López-Serna et al. (2012)
Spain 11.2–223 – – – – – – López-Serna et al. (2013)
Spain – 12–38 – – – – – Fernando-Climent et al. (2014)
Spain – 0.5–25 – – – – – Franquet-Griell et al. (2017)
USA – – – – – 8–44 7 Lara-Martín et al., 2014
USA – n.d. - 11.2 – – – – – Lara-Martín et al. (2015)
USA – – – – 93 – – Nödler et al. (2014)
China – 0.01–1.23 – – – – – Zhao et al. (2015)
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biochemical end-points (AChE, SOD, CAT, GST, GPx, LPO) were rinsed
with clean seawater and stored at−80 °C until further use. For the DNA
damage analysis coelomic cells of N. diversicolor (5 specimens per
aquaria, in triplicate; total of 15 organisms per treatment) were ex-
tracted from the posterior region of the polychaete body into 20 μL of
PBS buffer with a 0.5 mL-syringe fitted with hypodermic needle
(adapted from Lewis and Galloway, 2008).
2.2.1. Burrowing assay
The behavioural endpoint of the burrowing assay was verified only
over the exposure of N. diversicolor. Polychaetes from control condi-
tions, DMSO and TAM-exposed were submitted to a burrowing test after
the 14-days bioassay, according to Fonseca et al. (2017). Polychaetes (5
specimens per aquaria, in triplicate; total of 15 organisms per treat-
ment) were carefully and individually displaced from their test con-
tainers and transferred to 150mL-plastic flasks, filled with natural
seawater and 5 cm of sediments. The vertical position of polychaetes in
sediment column was recorded every 2min, to assess the time for fully
burrowing in the 30min-assay. The results are expressed as the per-
centage (%) of un-burrowed specimens, over time (min).
2.3. M. galloprovincialis in vivo bioassays
Mussels (5.2 ± 0.4 cm shell length) were collected in the Ria
Formosa coastal lagoon (Portugal; N 37° 0′ 29.4546″, W 7° 59′ 41.265″)
and acclimated over 5 days in tanks filled in natural seawater (salinity
35) under constant aeration and controlled photoperiod (12 h: 12 h
light/dark). Animals were fed with Tetraselmis chuii only during the
acclimation time, and water was renewed every other day in this
period. Afterwards, 150 mussels were randomly distributed in 20 L
glass tanks, in a duplicate design (75 mussels per treatment). They were
exposed over 14 days to DMSO (0.001%) and 100 ng L−1 of TAM,
jointly with unexposed mussels (CT0 and CT14).
Physico-chemical parameters were daily registered
(pH 7.86 ± 0.19; temperature 19 ± 1 °C; salinity 37.4 ± 0.5) and
water renewed every 48 h, following re-dosing of the drug or DMSO to
the water column. Mussels were fed only with the plankton present in
the natural seawater. By the end of the bioassay, no mortality was re-
gistered. Mussels were collected at the beginning of the experiment (T0)
and after 3, 7 and 14 days of exposure. Gills, digestive glands and go-
nads were dissected and immediately frozen in liquid nitrogen and
stored at −80 °C until further analysis of biochemical biomarkers
(AChE, ALP, SOD, CAT, GST, GPx, LPO).
2.3.1. M. galloprovincialis in vitro bioassays
Sixty mussels M. galloprovincialis (5.0 ± 0.5 cm shell length) were
handpicked in the Ria Formosa coastal lagoon and transported alive to
the laboratory, where they were placed in a 20 L-tank (1 animal per
0.33 L−1) filled with natural seawater (salinity 35 ± 1) and kept under
constant aeration. Animals were maintained over 48 h until haemo-
lymph extraction. Cells collection was performed according to the
procedure described in Section 2.3.2.
2.3.2. Sampling of mussel haemocytes
Cell extraction and incubation methods used were based on mod-
ifications of protocols developed by Gómez-Mendikute and Cajaraville
(2003) and Katsumiti et al. (2014). Haemolymph was extracted from
the posterior adductor muscle of the mussels with a sterile hypodermic
syringe (1mL) (25 G needle). About 300 μL of haemolymph was in-
dividually collected for cytotoxicity (3 specimens per aquaria, in du-
plicate; total of 6 organisms per treatment) and genotoxicity (3 speci-
mens per aquaria, in duplicate; total of 6 organisms per treatment),
then transferred into a 1.5mL microtube on ice (Gómez-Mendikute and
Cajaraville, 2003). The handling procedure was performed under
aseptic conditions in a vertical laminar airflow cabinet.
2.3.3. Cytotoxicity assessment
2.3.3.1. Cell counting and Trypan Blue assay. Firstly, 10 μL of
haemolymph was individually diluted in anti-aggregation solution
(171mM NaCl; 0.2M Tris; 0.15% v/v HCl 1 N; 24mM EDTA) in
order to avoid cell clumping and agglomeration (Katsumiti et al.,
2014). Cell staining was carried out through addition of trypan blue dye
(0.4% in physiological solution; v/v) in a proportion of 1:2 (cell
suspension: Trypan Blue 0.4%). Total cell counting was performed in
a Neubauer chamber (200 cells per specimen) with the use of a
haemocytometer and light microscopy (Olympus CH30). Cell viability
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2.3.3.2. Neutral Red (NR) Assay. The NR assay was adapted from the
protocol described in Olabarrieta et al. (2001) and Katsumiti et al.
(2014). After total cell counting, cell suspensions were diluted at a
density of 2×105 cells mL−1 (in anti-aggregation solution), and 100 μL
seeded into 96-well microplates (6 replicates per animal). Microplates
were centrifuged at 1200 rpm (10min, 4 °C), in order to assist cells to
settle and adhere. Supernatant was discarded, and cells of in vivo-
exposed animals were re-suspended in 100 μL of cell culture media
Dulbecco's Modified Eagle Medium (DMEM, pH 7.4).
Further, cells were incubated with 50 μL of neutral red working
solution (0.4%, pH 7) over 1 h, at 18 °C, in order to allow uptake of the
dye. Afterwards, cells were centrifuged at 1200 rpm for 10min, at 4 °C,
and carefully washed with PBS. The dye was then extracted from the
viable cells in acetic acid/ethanol solution (1:100), following samples
transference to U-bottom 96-well microplates and centrifuged at
1200 rpm, for 10min, at 4 °C. Supernatants were placed in flat bottom
microplates and absorbance measured at 550 nm (Infinite M200 Pro,
TECAN®).
2.3.4. Mussels haemocytes
Cell suspensions were diluted at a density of 2× 105 cells mL−1 (in
anti-aggregation solution), and 100 μL seeded into 96-well microplates
(6 replicates per animal; 3 animals per treatment). The in vitro cyto-
toxicity approach consisted in the incubation of haemocytes, extracted
from drug-unexposed mussels, exposed to DMSO and to increasing
concentrations of TAM (0; 0.0005, 0.025, 0.05, 0.1, 0.5, 1, 10 and 25 μg
TAM L−1, prepared in DMEM at 0.001% DMSO). Microplates were
incubated for 24 h at 18 °C. Afterwards, culture media was discarded,
following NR procedure described in detail in Section 2.3.3.1.
2.3.5. Human cells
The RPE and HeLa cell lines were cultured in Dulbecco's Modified
Eagle Media (DMEM). Immortalized RPE cell clones consist of a
transfected cell line with the catalytic component of human telomerase
(hTERT), which transient expression conserves telomers length without
converting to a neoplastic transformed phenotype (Bodnar et al., 1998).
HeLa cell line immortalized cells derived from cervical cancer tissues,
with a remarkable growth potential (Lucey et al., 2009).
Cells were allowed to grow until confluence and then detached by
trypsinization, then added to DMEM media, and maintained at 36 °C
under. Cell viability was determined by Trypan Blue exclusion before
cytotoxicity assessment. Further, the media was removed by aspiration
and the cells washed twice with PBS. A 100 μl aliquot of cell suspension,
containing 2×104 cells, was seeded per well in 96-well microplates
following incubation for 24 h at 36 °C for cell adherence. Afterwards,
supernatant was removed and TAM solution, prepared in DMEM culture
medium (at 0.001% DMSO), was seeded at an increasing range of TAM
concentrations (0, 0.5, 25, 50, 100, 500, 1000, 10,000, 25,000,
50,000 ng L−1). Cells were incubated over 24 h, at 36 °C, following NR
procedure (see Section 2.3.3.1).




Total proteins concentrations (mg protein g−1 tissue) were de-
termined according to the method described by Bradford (1976)
adapted for microplate reader, using bovine serum albumin (BSA) as a
standard.
2.4.2. ALP levels
The organic alkali-labile phosphate technique (Gagné and Blaise,
2000) was used to determine the vitellogenin content in the cytosolic
fraction of gonadal tissues of M. galloprovincialis. Sex-differentiated
gonads (3 specimens per aquaria, in duplicate; total of 6 organisms per
treatment) were homogenized in 25mM HEPES–NaOH buffer (pH 7.4)
and centrifuged (12,000×g, at 2 °C for 30min). Aliquots of super-
natants were used for total protein content determination according to
Bradford (1976) and ALP analysis, according to adaptations described
by Schmidt et al. (2011).
2.4.3. Neurotoxicity
AChE activity was determined in whole tissues of N. diversicolor (2
specimens per aquaria, in triplicate; total of 6 organisms per treatment)
and in gills ofM. galloprovincialis (3 specimens per aquaria, in duplicate;
total of 6 organisms per treatment). Samples were individually homo-
genized in 100mM Tris-HCl buffer (pH 8.0) with addition of 0.1%
Triton, following centrifugation at 12,000g, for 30min, at 4 °C.
Supernatants were split into aliquots for total protein determination
(Bradford, 1976) and AChE activity was analysed using the method of
Ellman et al. (1961) adapted to microplate reader.
2.4.4. Antioxidant enzymes
Antioxidant enzymes activities were determined in whole tissues of
N. diversicolor (2 specimens per aquaria, in triplicate; total of 6 organ-
isms per treatment) and in both gills and digestive glands of M. gallo-
provincialis (3 specimens per aquaria, in duplicate; total of 6 organisms
per treatment). Samples were individually homogenized in 20mM Tris-
HCl buffer (0.5M sucrose; 0.075M KCl; 1 mM DTT; 1mM EDTA; ad-
justed to pH 7.6 with HCl), according to the protocol described by
(Géret et al., 2002). Homogenates were centrifuged at 500 g, for 15min,
at 4 °C, and the supernatants obtained centrifuged again (12,000 g,
45 min, 4 °C). Enzymatic activities were analysed in the cytosolic frac-
tion. SOD activity was assessed by measuring the decrease of absor-
bance of the substrate cytochrome-c by xanthine oxidase/hypoxanthine
system, at 550 nm (McCord and Fridovich, 1969), and the results are
expressed as U mg−1 protein. CAT activity was evaluated through the
decrease of absorbance originated by hydrogen peroxide (H2O2) con-
sumption at 240 nm, according to Greenwald (1985). GPX activity was
measured at 340 nm by using cumene hydroperoxide and H2O2 as
substrates for T-GPx and Se-GPx, respectively (adapted from Lawrence
and Burk, 1976). The activity of CAT, Se- and T-GPx are expressed in
nmol min−1 mg−1 protein.
2.4.5. Biotransformation enzyme activity
The cytosolic fraction for the determination of GST activity was
obtained according the protocol described in Section 2.3.2. Measure-
ment of this biotransformation enzyme activity was conducted in whole
specimens of N. diversicolor (6 organisms per treatment) and tissues
(gills and digestive glands) of M. galloprovincialis (6 organisms per
treatment). Reaction mixture undergoes by the conjugation of 0.2mM
reduced glutathione (GSH) with 0.2mM CDNB (molar coefficient of
extinction=0.6mM−1 cm−1) in a reaction mixture of 0.2 M KH2PO4/
K2HPO4 buffer (pH 7.9), at 340 nm (adapted from Habig et al., 1974).
GST activity is determined in nmol min−1 mg−1.
2.4.6. Oxidative damage
Polychaetes N. diversicolor (6 organisms per treatment) and tissues
(gills and digestive glands) of M. galloprovincialis (6 organisms per
treatment) were individually homogenized in a Tris–HCl buffer
(20mM, pH 8.6) and butylated hydroxy toluene (BHT) (100:1 μL, re-
spectively). The resulting homogenates were centrifuged, for 45min at
30,000g at 4 °C, in order to obtain the cytosolic fraction. Aliquots of
supernatants were used for the quantification of total proteins
(Bradford, 1976) and determination of oxidative damage (Erdelmeier
et al., 1998), adapted for microplate reading. The absorbance of LPO
by-products, the malondialdehyde (MDA) and (2E)-4-hydroxy-2-
nonenal (4-HNE), was measured at 586 nm and expressed as nmol
MDA+4-HNE mg−1 protein.
2.5. Genotoxicity assay
Genotoxicity was estimated by the alkaline Comet assay, as de-
scribed in Fonseca et al. (2018), following the determination of the
amount of DNA in tail through the software Komet 5.5 (Kinetic Imaging
Ltd). Results are expressed as mean ± standard deviation (S.D.).
2.6. Statistical analysis
Statistical analysis was carried out using the Statistica 8.0 software
(Statsoft Inc., 2007, USA). The results were compared using parametric
tests (ANOVA, followed by the Tukey's test), or non-parametric
equivalent test (Kruskal-Wallis), according to data distribution and
variances homogeneity (Shapiro-Wilk and Levene's tests, respectively).
Results were significant when p < 0.05.
3. Results
3.1. Polychaete N. diversicolor
3.1.1. Burrowing behaviour
The percentage of polychaetes from CT0, CT14 and exposed to
DMSO buried were 100%, 90% and 90%, respectively, within 6min of
bioassay. In contrast, organisms exposed to the different TAM con-
centrations showed a general increase in burrowing time with the in-
crease of TAM concentrations exposure. Polychaetes treated with
25 ng L−1 and 100 ng L−1 failed to burrow after 4min and 26% and
53% of polychaetes, respectively, remained unburied (Fig. 2).
3.1.2. AChE activity
No differences in AChE activity were detected among controls (i.e.
CT0, CT14) and DMSO (p > 0.05) (Fig. 3). Polychaetes exposed to
TAM showed an induction of AChE activity, except for those exposed to
10 ng L−1.
3.1.3. Antioxidant enzyme responses
Overall, enzymatic activities of unexposed specimens (i.e. CT0,
CT14) and exposed to DMSO were similar (p > 0.05), with the ex-
ception of T-GPx that indicated an increase in DMSO exposed group. In
polychaetes exposed to the lowest TAM concentration (i.e. 0.5 ng L−1),
SOD activity increased compared to all other treatments (p < 0.05)
(Fig. 4-A). Although not significant (p > 0.05), there was an increasing
trend of SOD activity in the other TAM concentrations. Regarding CAT
activity, a significant inhibition occurred at the highest TAM con-
centration compared to control conditions (p < 0.05) (Fig. 4-B). The
activity of GPx-Se and T-GPx, like for SOD, also increased in poly-
chaetes exposed to 0.5 ng L−1 of TAM (p < 0.05) (Fig. 4-C and D) (2-
fold compared to controls).
3.1.4. Biotransformation enzyme activity
Relatively to GST activity, no significant alteration was observed
among treatments (p > 0.05) (Fig. 5).
T.G. Fonseca, et al. Environment International 129 (2019) 256–272
260
3.1.5. Oxidative damage
LPO levels in polychaetes controls and exposed to DMSO were si-
milar (p > 0.05). In contrast, the exposure of polychaetes to TAM in-
duced the generation of LPO by-products since there was a similar in-
crease of MDA+4HNE concentrations in all exposed animals
compared to controls (p < 0.05; Fig. 6).
3.1.6. Genotoxicity
Coelomocytes from control conditions (CT0, CT14 and DMSO) in-
dicated no significant changes in % of DNA tail (p > 0.05; Fig. 6). In
TAM-treated polychaetes, DNA damage was only addressed in speci-
mens exposed to the highest drug concentration (100 ng L−1)
(p < 0.05; Fig. 6).
3.2. M. galloprovincialis bioassay
3.2.1. ALP levels
In female gonads, with exception of those exposed to DMSO, a de-
creasing trend of ALP levels was observed over time, resulting in 1.4-
fold decrease of CT and TAM-exposed mussels compared to the initial
condition (p < 0.05). In males, although no significant differences over
time were detected (p > 0.05), ALP levels of TAM-exposed mussels
increased about 2-fold during the assay, with significant differences
compared to the respective controls, on days 7 and 14 (p < 0.05) while
those exposed to DMSO decreased.
3.2.2. Neurotoxicity
A sharp decrease in AChE activity was observed in mussels from all
treatments with significant differences over time (p < 0.05) (Fig. 9). In
TAM-treated gills, AChE activity was inhibited, compared to controls,
particularly at days 3 and 14 (p < 0.05).
3.2.3. Antioxidant enzymes
Enzymatic activity did not change over time in tissues of unexposed
mussels (p > 0.05), with exception of a SOD increase in gills from
animals exposed to DMSO in the last day of the experiment (p < 0.05)
(Fig. 9-A). SOD activity in TAM treated groups did not change in gills
during the 14 days of exposure (Fig. 10-A). In contrast, in digestive
glands, SOD activity increased after 3 days of TAM-exposure, followed
by its inhibition until the last day of experiment (p < 0.05) (Fig. 10-B).
Regarding CAT activity, no changes were detected in gills of un-
exposed mussels over the 14 days of experiment, although DMSO pre-
sented a slight increase only at the 3rd day of experiment (p < 0.05).
TAM-treated mussels showed significant fluctuations of CAT activity in
gills, presenting a 2-fold increase at the 3rd day following a 4.7-fold
inhibition at the 7th day (p < 0.05), until ultimately reaching levels
similar to controls (Fig. 10-C). CAT activity in digestive glands of un-
exposed mussels showed to decline over time, although not significant
(p > 0.05). Regarding drug-exposed mussels, CAT activity increased 5-
fold at the 3rd day, followed by a 4.7-fold decrease, at the 7th day, to
levels similar to the control group (Fig. 10-D).
3.2.4. Biotransformation enzyme activity
GST activity in gills from unexposed mussels remained unchanged
(p > 0.05). After 3 days of exposure, gills of TAM-contaminated mus-
sels showed a significant increase in enzymatic activity compared to
controls, following an inhibition trend until the end of the experiment,
although not significantly different from controls (p > 0.05) (Fig. 11).
A significant induction of GST activity was observed in digestive glands
of mussels from control, and those exposed to DMSO and to TAM, re-
garding the beginning of the experiment (p < 0.05).
3.2.5. Oxidative damage
Levels of LPO by-products were similar (p > 0.05) between mussels
from control conditions, in both gills and digestive glands (Fig. 12).
Regarding oxidative damage in gills of TAM-exposed mussels, LPO by-
products were significantly higher than controls over the entire ex-
periment (p < 0.05). In digestive glands of controls, levels of MDA and
Fig. 2. Percentage of unburied N. diversicolor over time (minutes) in controls (CT0; CT14) and exposed to DMSO and to TAM concentrations (0.5, 10, 25, 100 ng L−1).
Lines with symbols indicate the behaviour during the 30-min experiment.
Fig. 3. N. diversicolor AChE activity (mean ± S.D.) (ATC.min−1 mg−1 protein)
in unexposed (CT0; CT14) and exposed to DMSO and to TAM concentrations
(0.5, 10, 25 and 100 ng L−1). Different letters indicate significant differences
among treatments (One-way ANOVA; p < 0.05).
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4-HNE did not change significantly, whereas in TAM-exposed mussels
LPO levels increased over time with a 1.5-fold increment at the end of
the experiment (p < 0.05).
3.2.6. Cell viability
The results regarding the mussel assay using trypan blue dye are
depicted in Fig. 13. No significant differences in mussel cell viability
were detected during the 14 days of experiment, except for TAM-treated
mussels at the 7th and 14th days when compared with the beginning of
the assay (p < 0.05).
Regarding the results of mussels´ cell viability through NR dye
(Fig. 14), fluctuations in absorbance were registered in all conditions
with significant differences among times of exposure. Overall, Hae-
mocytes indicated an increase in viability, except at the 7th day, with
ultimate levels 3.3- and 4-fold higher than the initial condition, for
controls and TAM-exposed mussels, respectively (p < 0.05).
3.2.7. Genotoxicity
The DNA damage expressed as % of tail was selected to assess
genotoxicity caused by TAM exposure (Fig. 15). During the experiment,
no significant changes were detected in DNA damage in haemocytes
from unexposed mussels, although at the 14th day a slight increase was
Fig. 4. N. diversicolor antioxidant enzymes activities (mean ± S.D.) expressed in unexposed polychaetes (CT0; CT14) and exposed to DMSO and to a range of TAM
concentrations (0.5, 10, 25 and 100 ng L−1): (A) SOD, (B) CAT, (C) GPx Se-dependent, (D) T-GPx. Different letters indicate significant differences among treatments
(One-way ANOVA; p < 0.05).
Fig. 5. N. diversicolor GST activity (mean ± S.D.) in unexposed (CT0; CT14)
and exposed to DMSO and to TAM concentrations (0.5, 10, 25 and 100 ng L−1)
Absence of letters indicate no differences among treatments (One-way ANOVA,
Kruskal-Wallis; p > 0.05).
Fig. 6. N. diversicolor LPO levels (mean ± STD) (MDA+ 4-HNE nmol·mg−1
protein) in unexposed (CT0; CT14) and exposed to DMSO and to different TAM
concentrations (0.5, 10, 25 and 100 ng L−1). Different letters indicate sig-
nificant differences among treatments (One-way ANOVA; p < 0.05).
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registered in those exposed to the solvent (p > 0.05). Despite no sig-
nificant differences detected between DMSO and TAM-exposed mussels,
genotoxicity was always higher in haemocytes of mussels from the
drug-treated group (p > 0.05).
3.3. In vitro cytotoxicity assessments
3.3.1. M. galloprovincialis
In haemocytes, TAM produced a significant reduction in cell via-
bility at 0.5, 100, 500 ng L−1 and 10 μg L−1 (p < 0.05). Although the
wide range of increasing drug concentration, a dose-dependent cyto-
toxicity was not observed (Fig. 16).
3.3.2. Human cell viability
RPE cells were not affected by any of the TAM concentrations
(p > 0.05) (Fig. 17-A). In contrast, HeLa showed an increased viability
after 24 h when exposed to 100 ng L−1 of TAM. However, cytotoxicity
occurred at 500 ng L−1, 10 and 50 μg L−1 of TAM (p < 0.05), with the
absence of a dose-response profile (Fig. 17-B).
4. Discussion
Specific physicochemical properties of pharmaceuticals are known
to provide predictable behaviour and fate in aquatic compartments. The
high log Kow and low water solubility of TAM suggest a potential re-
moval from wastewater through drug adsorption onto sewage sludge
and sediments. However, detection of TAM in WWTPs effluents (con-
centrations up to 369 ng L−1) (Roberts and Thomas, 2006) confirm its
low removal efficiency (i.e. 17 to 43%) and drug recalcitrance over
conventional technologies that use sorption processes (Fernando-
Climent et al., 2014). Once released in the aquatic environment, besides
its residence in water column, pharmaceuticals compounds also sorb
onto suspended organic matter, clay, sediments and microorganisms,
that eventually settle in the bottom areas (Silva et al., 2011; Zenker
et al., 2014; Rocha et al., 2015). Therefore, differential uptake, trophic
transfer and bioaccumulation are experienced by aquatic species sub-
jected to different ways of exposure, via water or sediment contact,
although there is still a lack of information around TAM's bioavail-
ability, that may derive toxicological effects to non-target species
(Table 2) (Chapman and Wang, 2001; Du et al., 2014; Ribeiro et al.,
2015; Torres et al., 2009; Yamamoto et al., 2009).
4.1. Effects of tamoxifen in N. diversicolor
The present findings indicated that SOD and Se-GPx activities sig-
nificantly increase in polychaetes exposed to the lowest TAM con-
centration (0.5 ng L−1) (p < 0.05) (Fig. 2). SOD upregulation illus-
trates the prompt of the antioxidant system to overcome those toxic by-
products, by means of converting superoxide radical into less toxic
hydrogen peroxide (H2O2), following detoxification into water and
oxygen by GPx's (Gonzalez-Rey and Bebianno, 2014; van der Oost et al.,
2003). At the lowest TAM concentration, GPx may have exerted a cri-
tical compensatory mechanism over the unchanged CAT activity
(Cozzari et al., 2015; Marchi et al., 2017). The non-linear dose response
characterized by the lower dose stimulation (0.5 ng L−1) observed in
SOD and Se-GPx activities (Fig. 4), is referred as hormesis and may
include mechanisms to overcompensate alterations in homeostasis and
adaptive response based on inducible repair processes (Chapman, 2002;
Hoffmann, 2009). In other words, a small exposure to a stressful sti-
mulus increases the resistance of the cell or organism to a moderate or
severe level of stress (Arumugam et al., 2006; Hoffmann, 2009). Besides
repairing any damage, organisms also reduce background damage more
effectively (Chapman, 2002). The hormetic curve is described as non-
monotonic and biphasic shape, in which effects at low doses are op-
posite to those at high doses (Hoffmann, 2009). This kind of relation-
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1000 different environmental stressors (Chapman, 2002; Mater et al.,
2014), and is also attributed to the response of N. diversicolor exposed to
the lowest CP concentration (10 ng L−1) (Fonseca et al., 2018).
The increase of AChE activity in polychaetes N. diversicolor, fol-
lowing a concentration–response relationship (Fig. 3) was also observed
on M. galloprovincialis exposed to 75 ng L−1 of fluoxetine over two
weeks (Gonzalez-Rey and Bebianno, 2013), and on amphipods Ampe-
lisca brevicornis exposed to sediments spiked with 0.5 ng L−1 of ibu-
profen (Maranho et al., 2015). Likewise, Ruditapes phillipinarum showed
an AChE induction at single exposures to 0.1 μg L−1 of caffeine and
5 μg L−1 of ibuprofen, following its inhibition at the highest con-
centrations of pharmaceuticals (Aguirre-Martínez et al., 2016b). Ex-
planation for such increased neurosynaptic effect was hypothesized
according to particular drugs´ MoA, and also elucidated as a transitory
mechanism to overcome an AChE inhibition (Milan et al., 2013). Deng
et al. (2006) found that both anticancer drugs etoposide and excisanin
A, administered in rats, upregulated AChE expression during apoptosis,
in a mechanism driven by oxidative stress and activation of kinase
signalling cascade, proposing that AChE activity is raised in the pre-
sence of ROS. Ferreira et al. (2012) showed that an excess in AChE
levels in rats may display a reduction of cholinergic neurotransmission
efficiency and neurological dysfunctions, since the essential acet-
ylcholine is rapidly hydrolysed in the synaptic cleft. In this sense, im-
pairments in burrowing ability of polychaetes observed with the in-
crease of drug concentration (Fig. 2) may be linked to such neurotoxic
response. However, the burrowing impairment of N. diversicolor ad-
dressed afterwards exposure to cisPt at 100 ng Pt L−1 indicated a sig-
nificant dose-response relationship and correlation to the inhibition of
AChE activity (Fonseca et al., 2017), in contrast to findings of poly-
chaetes submitted to the alkylating agent cyclophosphamide, which
behavioural changes occurred as a result of the oxidative stress dis-
played by the drug rather than due to interferences of AChE levels
(Fonseca et al., 2018). Therefore, even though anticancer drugs are
generally classified as one therapeutic class, their specific MoAs may
ultimately modulate environmental stimuli that, in the case of bur-
rowing, has critical ecological consequences (Díaz-Jaramillo et al.,
2013; Sovová et al., 2014).
In the case of TAM administration to human patients, an increase in
enzymatic activity was registered for choline acetyltransferase, ac-
countable for the synthesis of the acetylcholine neurotransmitter cri-
tical for synapses (Silva et al., 2000). In mammalian brain, TAM acts as
an ER agonist and exerts estrogen-like effects associated to modulation
of neuroprotection and increase of human cognition, attention and
verbal skills (Dicko et al., 1999; McEwen and Alves, 1999; Newhouse
et al., 2013; Simpkins et al., 2009). Besides the beneficial effects of TAM
in human neuroactivity, there are still confounding factors in the
mammalian group itself related to features of hormonal status, age,
tissue-specific activation of ERs, and whether ERs possess ability to bind
estrogens or anti-estrogens at low concentrations (Lv et al., 2017;
Newhouse et al., 2013). At a concentration range from 0.1 to 50 μg L−1,
TAM was unable to alter AChE activity in the freshwater clam Corbicula
fluminea and disagree with the present observations, reinforcing that its
role as a receptor-estrogen modulator in invertebrates is far from clear
(Aguirre-Martínez et al., 2018).
The biotransformation enzyme, GST, conjugates reactions of active
electrophilic metabolites or their parental compounds with reduced
glutathione (GSH), enabling its transformation to more extractable
hydrophilic metabolites (Luis et al., 2016; van der Oost et al., 2003). In
addition, GST provides protection against ROS, playing a critical role in
the defence against oxidative damage d peroxidative products of DNA
and lipids (Nuwaysir et al., 1996). However, in human liver, TAM is
extensively metabolized by phase I cytochrome P450 and phase II
sulfotransferases (SULTs) and UDP-glucoronosyltransferases (UGTs)
(Kiyotani et al., 2012), whereas the mechanism by which TAM affects
GST expression is poorly studied. According to Nuwaysir et al. (1996),
TAM administration at relevant clinically therapeutic doses produce
significant suppression in GST mRNA expression in rat liver, resembling
the outcomes associated to cisplatin MoA (Fuertes et al., 2003). Herein,
the activity of GST did not change in polychaetes exposed to any TAM-
concentration, in contrast to the significant inhibition in N. diversicolor
specimens exposed to cisplatin at 100 ng Pt L−1 (Fonseca et al., 2017).
In the present case, either TAM metabolism may not be involved in GST
phase II enzyme, or the concentration range applied in the bioassay was
not enough to trigger this detoxification pathway.
In this study, TAM induced LPO in polychaetes exposed to all con-
centrations (Fig. 6). TAM embeds itself in the lipid membranes and
generates superoxide, which causes LPO and subsequent 4-HNE for-
mation, following activation of caspase-3 cascade and cell death
(Bekele et al., 2016). Such mechanism supports the contribution of
oxidative damage on killing cancer cells during TAM therapy. Inter-
ferences in the oxidative damage may be attributed either to the me-
tabolic activation of TAM in N. diversicolor, following production of
ROS, and/or by oxidative stress generated by TAM molecule intrusion
in the lipid bilayer, which does not depend on the prodrug metabolism
neither ERα expression and its activation (Bekele et al., 2016;
Lushchak, 2011; Trachootham et al., 2009).
Accordingly, the noteworthy DNA damage herein revealed in spe-
cimens exposed to the highest TAM concentration may be particularly
linked to activation of prodrug at such great drug levels (Fig. 7), since
the conversion of TAM into its intermediary putative active metabolite
α-hydroxytamoxifen is a pre-requisite for DNA covalent binding and
adducts formation (Boocock et al., 2002), as reported in human per-
ipheral blood lymphocytes and MCF-7 cells using alkaline Comet Assay
(Wozniak et al., 2007). Such explanation is plausible considering that
the antioxidant disruption shown in coelomocytes from 100 ng L−1
treatment only occurred through inhibition of CAT activity in addition
to levels of LPO by-products, that corroborate to those generated in all
tested TAM concentrations, hence comparable grades of oxidative da-
mage.
4.2. Effects of tamoxifen in M. galloprovincialis
Changes in ALP levels are positively related with those from vi-
tellogenin-like proteins, which are naturally synthesized in females and,
although present, are normally not expressed in males (Gonzalez-Rey
and Bebianno, 2012, 2013; Matozzo et al., 2008; Sun et al., 2009). This
biomarker has been used for endocrine disturbance assessment, since
Fig. 7. DNA damage (mean ± standard deviation) in coelomocytes of poly-
chaetes N. diversicolor unexposed (CT0; CT14) and exposed to DMSO and to
different TAM concentrations (0.5, 10, 25 and 100 ng L−1). Different letters
indicate significant differences among treatments (One-way ANOVA;
p < 0.05).
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the exposure of aquatic organisms to endocrine disruptors like xe-
noestrogens and estrogens present in the water trigger the increase of
vitellogenin levels in plasma (Sumpter and Jobling, 1995), indicating a
sex-specific response (Sun et al., 2009). Males of M. galloprovincialis
experienced a 2-fold increase of ALP after 14-days of exposure to ibu-
profen at 250 ng L−1 (Gonzalez-Rey and Bebianno, 2012, 2013). Simi-
larly, despite exposure at an unrealistic environmental concentration,
levels of vitellogenin-like proteins in males were induced after a 24-h
exposure to gemfibrozil, at 1 mg L−1 (Schmidt et al., 2011). Perturba-
tions in endocrine homeostasis were also addressed in M. gallopro-
vincialis collected in areas influenced by sewage effluents containing
chemicals with estrogenic properties and vitellogenin-like proteins
were induced both in male and female gonads (Pampanin et al., 2005).
In mussels exposed to TAM (concentrations of 0.1 to 50 μg L−1) an anti-
estrogenic potential was detected in the freshwater clam Corbicula flu-
minea, by reducing the levels of vitellogenin, although specimens were
not sex-differentiated (Aguirre-Martínez et al., 2018). Moreover, the
exposure of the adult male medaka Oryzias latipes to synthetic estrogen,
EE2 (200 ng L−1), induce 4× 103-fold of vitellogenin to levels com-
pared to unexposed males, whereas the co-exposure to TAM indicate an
anti-estrogenic potential by reducing the presence of this egg protein in
plasma (Sun et al., 2009). On the other hand, in the present study, ALP
levels significantly increase in males exposed to TAM (at the 7th and
14th days) (Fig. 8). In accordance, Rodenas et al. (2015) detected an
upregulation of hepatic vitellogenin mRNA in gilthead seabream after
fifty days under a dietary administration containing TAM (100 μg g−1).
These contrasting findings are in accordance to paradoxical agonist
interference of TAM towards ERs, able to trigger estrogenic disruptive
mechanisms besides the anti-estrogenic designed MoA. The variable
responses depend on particular interactions specific to cell types
(García-Hernández et al., 2016), and it is also accountable for causing
side effects in bones and uterus of patients under breast cancer treat-
ment (Love et al., 1992; O'Regar and Gradishar, 2001). In this sense,
TAM acts as a xenoestrogen in certain species and lead to the impair-
ment of reproductive fitness or ultimately to feminization of male
aquatic organisms (Gonzalez-Rey and Bebianno, 2012, 2013).
In contrast to N. diversicolor, M. galloprovincilis revealed an inhibi-
tion of AChE activity during TAM exposure (Fig. 9). AChE inhibitors
impair the cholinesterase enzyme from breaking down acetylcholine,
critical for synapses and maintenance of memory processes, increasing
both the level and duration of the neurotransmitter action (Colovic
et al., 2013). Data available in the literature indicate that pharmaceu-
ticals are relevant neurotoxic agents to aquatic organisms (Luis et al.,
2016; Maranho et al., 2015; Milan et al., 2013; Munari et al., 2014).
However, it is important to bear in mind that even though pharma-
ceuticals are grouped as one type of emerging contaminants able to
trigger neuronal disturbance by altering AChE activity, the vast array of
therapeutic classes and their designed MoA in combination to species-
specific properties (e.g. presence/absence of critical receptors, genes
encoding enzymes for drug metabolism) lead to differential molecular
docking, activation of biochemical pathways, detoxification metabo-
lism and, finally, toxicological responses.
Similar to polychaetes, mussels exposed to TAM showed an induc-
tion of SOD in digestive glands (Fig. 10-B). In the present study, after
7 days of exposure, CAT levels were significantly reduced in gills of
TAM-treated specimens, whereas no SOD alteration occurred, as in
polychaetes N. diversicolor submitted to 100 ng L−1 (Fig. 4-B). SOD
activity increased in digestive glands at the 3rd day of exposure (Fig. 9-
B), corroborating the results obtained by Trombini et al. (2016), for M.
galloprovincialis exposed CisPt (100 ng L−1). In addition, digestive
glands of mussels exposed to TAM also showed a 3-fold increase in CAT
activity (Fig. 9), and indicates an early activation of antioxidant me-
chanisms, to counteract prooxidant forces and consequent damage.
Since SOD represents a source of hydrogen peroxide, catalase is an
extremely active and critical catalyst for the reduction of H2O2 to H2O
(Halliwell and Gutteridge, 2007), thus preventing these ROS to be
converted to hydroxyl radicals through Fenton reaction, which are re-
active initiators of membrane lipid peroxidation (Regoli and Giuliani,
2014).
Herein, gills of mussels exposed to TAM showed a significant GST
induction at the 3rd day of exposure (Fig. 10-A), jointly with the CAT
activity increase. In ROS-generating conditions, CAT and GST activities
are pertinent to restore the cellular homeostasis before irreversible
Fig. 8. M. galloprovincialis ALP levels (mean ± STD) in sex-differentiated go-
nads (A: females; B: males), unexposed (CT) and exposed to DMSO and to TAM
(100 ng L−1) for 14 days. Capital and lower letters indicate significant differ-
ences among treatments of the same sampling day, and the same treatment over
different days (One-way ANOVA; p < 0.05).
Fig. 9. M. galloprovincialis AChE activity (mean ± STD) (ATC min−1 mg−1
protein) in gills unexposed (CT) and exposed to DMSO and to TAM
(100 ng L−1), over 14 days. Capital and lower letters indicate significant dif-
ferences among treatments of the same sampling day, and the same treatment
over different days (One-way ANOVA; p < 0.05).
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damage occurs (Capolupo et al., 2016; Regoli and Giuliani, 2014). The
basal GST activity in gills ofM. galloprovincialis is three-fold higher than
in digestive glands. Biotransformation response in digestive glands of
Perna perna did not exhibit significant alterations at the diclofenac
concentrations tested (20, 200 and 2000 ng L−1) (Fontes et al., 2018).
In bivalves, digestive glands play a key role in absorption, metabolism
and accumulation of xenobiotics, especially pharmaceuticals, and are
thus considered an ideal tissue for estimating detoxification pathways,
adverse effects of drugs to comprehend their MoA in this biological
model (Canesi et al., 2007a, 2007b; Capolupo et al., 2016; Franzellitti
et al., 2014). Despite proclaimed that induction of GST activity in gills
could result from an attempt of ROS scavenging in this tissue rather
than a biotransformation mechanism, acting in conjunction with CAT
induction at the 3rd day (Regoli and Giuliani, 2014). In addition, the
absence of upregulation of GST in digestive glands is also in agreement
with the responses observed with N. diversicolor. Moreover, since GST
and GPx use reduced glutathione (GSH) as electron donor for reducing
H2O2 to H2O, the absence of alterations in GST in digestive glands could
be attributed to the competition for the substrate by both enzymes
(Trombini et al., 2016). Therefore, further studies are needed to clarify
comparisons regarding TAM pharmacodynamic in marine organisms
and humans and comprehend if metabolic activation undergo via the
same pathways.
Generation of LPO by-products occurred in gills, 4-fold higher than
the oxidative damage elicited in digestive glands (Fig. 11). According to
Bekele et al. (2016), TAM has a killing-cell potential that may be in-
dependent of ERα expression, since the drug binds to lipid membranes
following ROS formation and oxidative damage. Although the lower
range of antioxidant and biotransformation activity in TAM-exposed
digestive glands, compared to gills, mechanisms of defence were en-
ough to counteract the action of reactive metabolites (Teles et al.,
2016).
Regarding cytotoxicity obtained through Trypan Blue exclusion
assay, no significant alterations in cell viability of TAM-exposed mussel
were detected (Fig. 13). In contrast, results obtained by the NR method
showed strong fluctuations and significant temporal differences in dye
retention (Fig. 14). In a cytotoxicity assessment conducted with gran-
ulocytes of the European lobster Homarus gammarus exposed to com-
mercial immunoestimulants, the NR assay exhibited a higher sensitivity
relative to trypan blue exclusion, respectively indicating 0 and 56% of
Fig. 10. M. galloprovincialis antioxidant enzymes activity (mean ± STD) of (A-B) SOD and (C-D) CAT in gills and digestive glands of unexposed (CT) and exposed to
DMSO and to TAM (100 ng L−1) for 14 days. Capital and lower letters indicate significant differences among treatments of the same sampling day, and the same
treatment over different days (One-way ANOVA; p < 0.05).
Fig. 11. M. galloprovincialis GST activity (mean ± STD) (nmol CDNB
min−1 mg−1 protein) in gills (A) and digestive glands (B) of unexposed (CT)
and exposed to DMSO and to TAM (100 ng L−1), over 14 days. Capital and
lower letters indicate significant differences among treatments of the same
sampling day, and the same treatment over different days (One-way ANOVA;
p < 0.05).
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cell viability (Hauton and Smith, 2004). Such difference may be at-
tributed to the fact that these methods measure different aspects of cell
physiology. A reduction in NR uptake reflects a decrease in lipid
membrane stability, which would usually precede cell death, whereas
trypan blue only enters cells when the membranes become disrupted, a
process which occurs at the time of, or shortly after, cell death. How-
ever, in the present study, results indicated a continuous increase in cell
viability in all treatments with time, ultimately culminating in a higher
dye retention in TAM-treated mussels in comparison to controls. Miller
et al. (2015) detected comparable results, in NR absorbance following
in vivo exposure ofMytillus sp. to single (250 and 500 μg L−1) and multi-
walled nanocarbon (500 μg L−1) were higher than unexposed ones.
Fig. 12. M. galloprovincialis LPO by-products (mean ± STD) (nmol
MDA+4HNE mg−1 protein) in gills (A) and digestive glands (B) of unexposed
(CT) and exposed to DMSO and to TAM (100 ng L−1) for 14 days. Capital and
lower letters indicate significant differences among treatments of the same
sampling day, and the same treatment over different days (One-way ANOVA;
p < 0.05).
Fig. 13. M. galloprovincialis Cell viability (% of viable cells) using Trypan Blue
dye in haemocytes, unexposed (CT), DMSO and exposed to TAM (100 ng L−1),
at different times for 14 days. Capital and lower letters indicate significant
differences among treatments of the same sampling day, and the same treat-
ment over different days (One-way ANOVA; p < 0.05).
Fig. 14. M. galloprovincialis Cell viability (% of viable cells) using Neutral Red
dye in haemocytes unexposed (CT), 0.001% DMSO and exposed to TAM
(100 ng L−1), for14 days. Capital and lower letters indicate significant differ-
ences among treatments of the same sampling day, and the same treatment over
different days (One-way ANOVA; p < 0.05).
Fig. 15. M. galloprovincialis DNA (mean ± standard deviation) in tail measured
in mussel haemocytes unexposed (CT), DMSO (0.001%) and exposed to 100 ng
TAM L−1, for 14 days. Capital and lower letters indicate significant differences
among treatments of the same sampling day, and the same treatment over
different days (One-way ANOVA; p < 0.05).
Fig. 16. M. galloprovincialis cell viability (Neutral Red Assay) of unexposed (CT)
and exposed to TAM. Asterisks indicate significant differences between control
and TAM-exposed cells (t-test; p < 0.05).
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They suggested that this cytotoxic method performed in microplate was
unable to detect a concentration-dependent toxic impairment to mussel
haemocytes following in vivo exposure, contrarily to the successful re-
sults reported in in vitro incubations. According to Weyermann et al.
(2005) and Fotakis and Timbrell (2006), different cytotoxicity assays
can provide different results depending on the test agent. In addition,
divergent of such profile of cytotoxicity is the genotoxicity responses,
which demonstrated a higher % of DNA in tail of haemocytes exposed
to TAM which were in accordance with damage effects. Partitioning of
TAM into cell membrane generates a transmembrane signal transduc-
tion cascade mediated by protein kinases, involved both in cell pro-
liferation and apoptosis. Previous clinical trials revealed that TAM
triggers apoptotic signalling cascade in human cell lines that either
express and do not express ERs, and once activation of ERK, JNK and
p38 kinases is suppressed, reducing cell viability blocked jointly with
apoptosis (Mabuchi et al., 2004). Therefore, it is of relevant interest to
speculate if mechanisms of kinase in mussels are activated by TAM, as
an alternative mechanism to interfere in cell viability and apoptosis,
disregarding from ERs sensitivity and consequent TAM metabolites
generation.
4.3. Cytotoxic effects of tamoxifen on cells in vitro
In vitro techniques could provide valuable tools to rapidly screen the
toxicity caused by pharmaceuticals and allow the detection of re-
lationships between experimental animals and humans (IARC). Besides,
it is of relevant importance to determine whether in vitro assays de-
veloped with non-targeted species can predict drug metabolism from
their in vivo exposure. However, to date, no studies pertaining exposure
of primary cells of marine organisms to anticancer drugs were con-
ducted. In the present study, the cytotoxicity observed in ER-negative
HeLa cells, against the absence of cytotoxic effect in the ER-positive
RPE cells, suggests that the mechanism accountable for the drug MoA
was related to a pathway other than binding to membrane receptor.
According to Cabot et al. (1997), the interaction of TAM with mem-
brane enzymes, like protein kinase C, or with the lipid phase of cell
membranes, affects both its physical properties and chemical compo-
sition, besides able to trigger membrane responses that ultimately in-
fluence nuclear events (Cabot et al., 1997; Engelke et al., 2002).
Ma et al. (2015) addressed that TAM effects may be independent of
estrogen signalling. The decrease in RPE cell viability obtained from
WST-1 and Trypan Blue exclusion assays did not reveal a reliable clue of
necrosis, demonstrating that TAM induced cytotoxicity via cell cycle
arrest and pyknosis (i.e. fragmentation of nucleus, although cytoplasmic
membrane is intact). Besides, it is important to bear in mind that the
TAM concentration range of exposure, 106 to 108 lower than the ther-
apeutic doses usually tested in in vitro studies conducted with human
cell lines (i.e.1 to 100 μM), may be the reason to the experienced lack of
responses (Engelke et al., 2002).
In this sense, cytotoxic responses elicited by TAM to both ER-ne-
gative cells, mussels´ haemocytes and HeLa, could be attributed to
membrane-related mechanisms other than ER signalling, although
further studies are needed in order to test the pathways involved.
Despite indicating similar responses of cytotoxicity at the intermediary
TAM concentrations (500 and 10,000 ng L−1) in vitro mussels exhibited
a higher sensitivity to the drug by means of a non-monotonic response
at the lowest concentration (0.5 ng L−1), which did not trigger any ef-
fect in the human counterpart. Such low observed effect concentration
(LOEC) comprises an environmental realistic level of TAM concentra-
tion that highlights the real risk for non-target organisms. As far as we
know, this is the first report on the cytotoxic effects of anticancer drugs
on marine organisms in vitro, particularly in mussels´ cells.
In addition, research on biological effects of pharmaceuticals con-
firmed non-monotonic dose responses at lower exposure doses, in a
variety of endpoints (Mezzelani et al., 2018). According to Lagarde
et al. (2015), endocrine disrupting chemicals are regularly associated to
this profile of dose-response, representing a challenge to fundamental
concepts in toxicology and risk assessment that characterizes a hazard
according to an increasing toxicant dose. Similarly, the non-monotonic
profile of cytotoxicity detected in M. galloprovincialis was also detected
in in vitro hepatic human cells (HEPG2) exposed to TAM (0.1 to
10 μg L−1) (Mater et al., 2014), which reinforces the use of haemocytes
in in vitro approaches screening the cytotoxicity of emergent con-
taminants like anticancer drugs.
5. Conclusions
Our present findings confirmed that the prodrug TAM elicits detri-
mental impacts at environmental realistic concentrations in both
polychaetes and mussels, through in vivo and water-borne exposure,
disregarding the aquatic compartment and form of uptake. TAM causes
hormetic responses in N. diversicolor and M. galloprovincialis in vivo-
exposed, as well as in haemocytes of M. galloprovincialis incubated in
vitro, at 0.5 ng L−1. These results highlight the risks to which coastal
species are chronically subjected. Although both biological models are
ERs-positive, enabling drug metabolic activation and apoptotic out-
comes, the generation of oxidative stress, membrane damage, and
Fig. 17. Human Cell viability (Neutral Red Assay) of RPE (A) and HeLa (B) cells
exposed to TAM. Asterisks indicate significant differences between control (CT)
and TAM-exposed cells (t-test; p < 0.05). (For interpretation of the references
to colour in this figure legend, the reader is referred to the web version of this
article.)
T.G. Fonseca, et al. Environment International 129 (2019) 256–272
268
genotoxicity are attributed to the direct contact of prodrug to cyto-
plasmic membrane. In this sense, it is relevant to determine whether
TAM acts as an agonist and antagonist in the tissue of analysis, and also
to which extent the presence of ERs is crucial for cell growth inhibition
in non-target organisms. Overall, in inclusion the in vitro approach with
mussels´ cells indicated comparable sensitivity to human cell line
(HeLa) and showed to be a feasible tool for the assessment of en-
vironmental risk caused by anticancer drugs.
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